Clinical Trial: Comparing the Efficacy and Safety of Vericiguat With Standard Medical Treatment in Heart Failure Patients

U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07697833) titled 'Comparing the Efficacy and Safety of Vericiguat With Standard Medical Treatment in Heart Failure Patients' on June 30.

Brief Summary: To compare the effectiveness and safety of Vericiguat with Standard Medical Treatment in Patients with Heart Failure and Reduced Ejection Fraction

Study Start Date: July 15

Study Type: INTERVENTIONAL

Condition: Heart Failure With Reduced Ejection Fraction (HFrEF)

Intervention: DRUG: Vericiguat tablet

Vericiguat 10 mg (titrated from 2.5 mg, to 5 mg, and to 10 mg), on a background of standard of care

DRUG: Placebo

Participants will receive a matching placebo tablet. The placebo will follow the ...